コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
4 ased cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders
5 s of cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders
7 included autistic features, mood disorders, obsessive-compulsive behaviors and hetero- and autoaggre
8 dromal clinical research program with severe obsessive-compulsive behaviors and subthreshold symptoms
10 ce of comorbid difficulties, including tics, obsessive-compulsive behaviors, and attention deficit hy
12 dation, hyperactivity, cognitive impairment, obsessive-compulsive behaviour, seizure activity and aut
14 atures: depression, irritability/aggression, obsessive/compulsive behaviours, apathy and psychosis.
17 f Default Mode Network (DMN) deactivation in Obsessive Compulsive Disorder (OCD) in the transition be
18 ractivity in the CSTC pathway is involved in obsessive compulsive disorder (OCD), a neuropsychiatric
19 TC) circuit dysregulation is correlated with obsessive compulsive disorder (OCD), causation cannot be
23 the priest or asipu; other disorders such as obsessive compulsive disorder and psychopathic behaviour
24 siderable implications for disorders such as obsessive compulsive disorder and schizophrenia, in whic
26 rols converge with the effective contacts in obsessive compulsive disorder patients localized within
28 sess decisional impulsivity in subjects with obsessive compulsive disorder who have undergone deep br
29 on's disease (PD), addiction, schizophrenia, obsessive compulsive disorder, and Tourette's syndrome.
30 tal illnesses including depression, anxiety, obsessive compulsive disorder, autism and eating disorde
31 ment disorders such as Tourette syndrome and obsessive compulsive disorder, in which patients are dri
32 ders, including epilepsy, stroke, psychoses, obsessive compulsive disorder, phobias, psychopathic beh
36 specific phobia (24%), panic disorder (16%), obsessive-compulsive disorder (9%), and bipolar I disord
41 family studies have consistently found that obsessive-compulsive disorder (OCD) aggregates in famili
42 CBT) has been established as efficacious for obsessive-compulsive disorder (OCD) among older children
43 individuals with mental disorders other than obsessive-compulsive disorder (OCD) and among people wit
44 .1 (1.6); the mean number was 0.9 (1.3) when obsessive-compulsive disorder (OCD) and attention-defici
45 diagnosis effects of TS as well as comorbid obsessive-compulsive disorder (OCD) and attention-defici
46 e also symptomatic of psychopathologies like obsessive-compulsive disorder (OCD) and autism spectrum
47 sights into understanding conditions such as obsessive-compulsive disorder (OCD) and drug addiction;
49 ostriatal circuits in the pathophysiology of obsessive-compulsive disorder (OCD) and OC-spectrum diso
51 e examined behavioral alterations related to obsessive-compulsive disorder (OCD) and the role of TNFa
52 ive functioning are present in patients with obsessive-compulsive disorder (OCD) and their first-degr
53 tion has been linked with the development of obsessive-compulsive disorder (OCD) and tic disorders, a
54 ration on perseverative behaviors related to obsessive-compulsive disorder (OCD) and Tourette syndrom
57 t core deficits in goal-directed behavior in obsessive-compulsive disorder (OCD) are caused by impair
60 M) abnormalities have long been suspected in obsessive-compulsive disorder (OCD) but the available ev
66 ults from structural neuroimaging studies of obsessive-compulsive disorder (OCD) have been only parti
69 ant literature on the treatment of pediatric obsessive-compulsive disorder (OCD) indicates that parti
73 variants, even when genomic data are limited.Obsessive-compulsive disorder (OCD) is a neuropsychiatri
79 rovided consistent support for the idea that obsessive-compulsive disorder (OCD) is associated with d
84 tive behavior therapy (CBT) among youth with obsessive-compulsive disorder (OCD) is effective, but ma
86 risk of death by suicide in individuals with obsessive-compulsive disorder (OCD) is largely unknown.
94 te syndrome/chronic tic disorder (TS/CT) and obsessive-compulsive disorder (OCD) overlap in their phe
95 t-degree relatives of these SCZ patients, 13 obsessive-compulsive disorder (OCD) patients, 18 unaffec
96 nce with Deep Brain Stimulation for treating obsessive-compulsive disorder (OCD) patients, we suggest
98 -related potential, is a reliable finding in obsessive-compulsive disorder (OCD) research and may be
99 on-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD) share impaired inhib
101 and structural imaging studies suggest that obsessive-compulsive disorder (OCD) symptoms arise from
103 sed for the treatment of chronic depression, obsessive-compulsive disorder (OCD), and anxiety-related
104 netic relationships among Tourette syndrome, obsessive-compulsive disorder (OCD), and attention defic
105 epression is a commonly occurring symptom in obsessive-compulsive disorder (OCD), and is associated w
106 ve disorders (DDs), anxiety disorders (ADs), obsessive-compulsive disorder (OCD), and posttraumatic s
107 ral therapy (CBT) is effective for pediatric obsessive-compulsive disorder (OCD), but non-response is
108 atum (VC/VS) reduces symptoms of intractable obsessive-compulsive disorder (OCD), but the mechanism o
109 ecognizes hoarding disorder as distinct from obsessive-compulsive disorder (OCD), codifying a new con
110 der (HD), previously considered a subtype of obsessive-compulsive disorder (OCD), has been proposed a
111 the first-line pharmacological treatment for obsessive-compulsive disorder (OCD), have two limitation
112 ogic and cognitive behavioral treatments for obsessive-compulsive disorder (OCD), some patients conti
113 Stimulated by the ego-dystonic nature of obsessive-compulsive disorder (OCD), where compulsive ac
114 In mice, genetic deletion of Sapap3 causes obsessive-compulsive disorder (OCD)-like behaviors that
115 tability in the thalamocortical circuits and obsessive-compulsive disorder (OCD)-like grooming behavi
116 moval dysfunction similar to humans with the obsessive-compulsive disorder (OCD)-spectrum disorder, t
135 [ADHD], autism spectrum disorder [ASD], and obsessive-compulsive disorder [OCD]) share genetic vulne
137 that compulsive behaviors, characteristic of obsessive-compulsive disorder and addiction, are driven
139 on in disorders as diverse as schizophrenia, obsessive-compulsive disorder and autism, and suggests t
140 ders are common and are suggested to include obsessive-compulsive disorder and behaviours, attention
141 iatric disorders that include schizophrenia, obsessive-compulsive disorder and bipolar disorder (BD).
143 ment current models of symptom generation in obsessive-compulsive disorder and may enable the develop
144 ded for some mental health disorders such as obsessive-compulsive disorder and post-traumatic stress
145 onin reuptake inhibitors for childhood-onset obsessive-compulsive disorder and the anxiety disorders,
146 ction in neuropsychiatric conditions such as obsessive-compulsive disorder and Tourette syndrome rema
147 ngulotomy and capsulotomy for depression and obsessive-compulsive disorder are considered 'establishe
149 nterventions are available for management of obsessive-compulsive disorder in adults, but few studies
150 ements for 608 genes potentially involved in obsessive-compulsive disorder in human, dog, and mouse.
151 alcohol use disorders in nonblack women, and obsessive-compulsive disorder interacted with drug use d
155 s a biological basis that schizophrenia with obsessive-compulsive disorder is a distinct subtype of s
165 oval, similar to behavior in humans with the obsessive-compulsive disorder spectrum disorder trichoti
166 le study of posttraumatic stress disorder or obsessive-compulsive disorder to date, although there is
167 hifts evidence accumulation in subjects with obsessive-compulsive disorder towards a functional less
168 14-week randomized clinical trial (Pediatric Obsessive-Compulsive Disorder Treatment Study for Young
171 as, panic, generalized anxiety disorder, and obsessive-compulsive disorder), substance use disorder (
172 major depressive disorder, 0.6% vs. 7.1% for obsessive-compulsive disorder, 2.5% vs. 6.7% for panic d
173 d a 69% (95% CI, 46%-94%) increased risk for obsessive-compulsive disorder, a 21% (95% CI, 11%-33%) i
174 al phobia, specific phobia, agoraphobia, and obsessive-compulsive disorder, all dimensional scores us
175 umans for the treatment of major depression, obsessive-compulsive disorder, and addiction, may also b
177 ia, bipolar disorder, depression, addiction, obsessive-compulsive disorder, and anxiety), we found th
179 ader-Willi syndrome, affective disorders and obsessive-compulsive disorder, and polymorphisms of V1a
180 ms includes postpartum major mood disorders, obsessive-compulsive disorder, and psychosis with infant
181 s conditions, including end-of-life anxiety, obsessive-compulsive disorder, and smoking and alcohol d
182 nxiety disorder, agoraphobia, social phobia, obsessive-compulsive disorder, anorexia, or substance ab
183 tal regions in the etiology and treatment of obsessive-compulsive disorder, anxiety, and depression,
184 ment of various comorbid conditions, such as obsessive-compulsive disorder, attention deficit hyperac
185 toms in addition to schizophrenia, including obsessive-compulsive disorder, autism, and alcoholism, o
186 erventions is effective in the management of obsessive-compulsive disorder, but considerable uncertai
187 n effective treatment for therapy-refractory obsessive-compulsive disorder, but its effect on dopamin
188 rders, aggressiveness and violence in crime, obsessive-compulsive disorder, depression, suicide, schi
189 s including depression, Parkinson's disease, obsessive-compulsive disorder, essential tremor, addicti
191 fully to investigate substance addiction and obsessive-compulsive disorder, in a potentially new spec
192 he most common diagnoses, mood disorders and obsessive-compulsive disorder, includes serotonergic dru
193 ith several psychiatric disorders, including obsessive-compulsive disorder, major depressive disorder
194 ders, particularly behavioral addictions and obsessive-compulsive disorder, may be due to neurochemic
195 in lOFC, which is known to be hyperactive in obsessive-compulsive disorder, may be responsible for im
196 ory, we compared two groups of patients with obsessive-compulsive disorder, one unmedicated (n = 12)
197 panic disorder with or without agoraphobia, obsessive-compulsive disorder, or posttraumatic stress d
198 t agoraphobia, generalized anxiety disorder, obsessive-compulsive disorder, or social anxiety disorde
199 t/outpatient diagnoses of anxiety disorders, obsessive-compulsive disorder, posttraumatic stress diso
200 ntion should be paid to anxiety, depression, obsessive-compulsive disorder, psychosis, personality di
202 isorders, with higher levels associated with obsessive-compulsive disorder, schizophrenia, and anxiet
203 essive-compulsive spectrum disorders such as obsessive-compulsive disorder, Tourette's syndrome, path
204 keeping with the model of habit formation in obsessive-compulsive disorder, we hypothesized that this
206 ure describing novel mouse genetic models of obsessive-compulsive disorder-like behaviors and neurobi
232 associated with benefits in the treatment of obsessive-compulsive disorder; however, adverse events w
233 al phobia, specific phobia, agoraphobia, and obsessive-compulsive disorder; these dimensional scores
235 pression, fragile X syndrome (FXS), anxiety, obsessive-compulsive disorders, and levodopa induced dys
241 (PG) has been variously conceptualized as an obsessive-compulsive (OC) spectrum disorder or as an add
242 sonality disorders (borderline, schizotypal, obsessive-compulsive, or avoidant) or a DSM-IV diagnosis
243 ween obsessive-compulsive disorder (OCD) and obsessive-compulsive personality disorder (OCPD) has lon
244 showed a significantly higher prominence of obsessive-compulsive personality disorder (OCPD) in the
248 n anxiety disorder or in a group of putative obsessive-compulsive-related disorders is still a matter
249 severity, including the modified Yale-Brown Obsessive Compulsive Scale (NE-YBOCS); total scores rang
250 a primary diagnosis of OCD and a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score of 16 or highe
252 oup and changes in the Children's Yale-Brown Obsessive Compulsive Scale and Clinical Global Impressio
254 B-CBT and FB-RT on the Children's Yale-Brown Obsessive Compulsive Scale at week 14 was 0.84 (95% CI,
255 dex and a modified version of the Yale-Brown Obsessive Compulsive Scale for hypochondriasis (H-YBOCS-
257 25% improvement on the Children's Yale-Brown Obsessive Compulsive Scale modified for Pervasive Develo
258 .66 [0.03]; corresponding to mean Yale-Brown Obsessive Compulsive Scale score change, -60% [19] vs -1
259 rimary diagnosis and a Children's Yale-Brown Obsessive Compulsive Scale score of 16 or higher despite
261 ssessment point on the Children's Yale-Brown Obsessive Compulsive Scale total score (estimate, -2.31,
262 ficant declines in the Children's Yale-Brown Obsessive Compulsive Scale total score and Clinical Glob
263 diagnosis of OCD and a Children's Yale-Brown Obsessive Compulsive Scale total score of 16 or higher.
266 linical Interview for DSM-IV, the Yale-Brown Obsessive Compulsive Scale, and the Saving Inventory-Rev
267 the primary efficacy measure, the Yale-Brown Obsessive Compulsive Scale, of >/=35% over the 3-year fo
268 ary outcome measures included the Yale-Brown Obsessive Compulsive Scale, the Hamilton Depression Rati
269 OCD symptoms, measured using the Yale-Brown Obsessive Compulsive Scale-Observer-Rated (Y-BOCS-OR) at
272 th the compulsion subscale of the Yale-Brown Obsessive Compulsive Scale; the Clinical Global Impressi
274 te to severe OCD (mean Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)=28.2 +/- 3.7), 17 o
276 ments were investigated using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Hamilton Dep
277 al analog scale (OCD-VAS) and the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) were used to assess
278 ely to treatment by improving their baseline obsessive-compulsive scale score by 30% or more and demo
279 ween fear extinction deficits and Yale-Brown Obsessive-Compulsive Scale symptoms in OCD suggest that
283 e was the score on the Children's Yale-Brown Obsessive Compulsive Scales modified for pervasive devel
284 score reduction on the Children's Yale-Brown Obsessive Compulsive Scales modified for pervasive devel
285 iors measured with the Children's Yale-Brown Obsessive Compulsive Scales modified for pervasive devel
286 ment of neuropsychiatric conditions, such as obsessive compulsive spectrum disorders and schizophreni
287 tributing to the development and severity of obsessive-compulsive spectrum disorders such as obsessiv
288 useful treatment for patients suffering from obsessive-compulsive spectrum disorders with high impuls
289 iatric disease, including Tourette syndrome, obsessive-compulsive spectrum disorders, eating disorder
292 bo, 0%) and 1.8 for CGI-rated improvement in obsessive-compulsive symptoms (responders: fluoxetine, 5
293 vement scale was used to rate improvement in obsessive-compulsive symptoms and overall severity.
295 Moreover, by showing that schizophrenia and obsessive-compulsive symptoms could be modeled in animal
298 al measures of inattention, social deficits, obsessive-compulsive symptoms, and general adaptive func
299 -Brown compulsion subscale and CGI rating of obsessive-compulsive symptoms, as well as on the CGI ove
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。